Cargando…
Intravenous allogeneic umbilical cord blood–derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients
BACKGROUND: Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable disease that causes severe mucocutaneous fragility due to mutations in COL7A1 (encoding type VII collagen [C7]). In this phase I/IIa trial, we evaluated the safety and possible clinical efficacy of intravenous infusion of...
Autores principales: | Lee, Sang Eun, Lee, Seung-Ju, Kim, Song-Ee, Kim, Kinam, Cho, Boyoung, Roh, Kyounghwan, Kim, Soo-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934866/ https://www.ncbi.nlm.nih.gov/pubmed/33491668 http://dx.doi.org/10.1172/jci.insight.143606 |
Ejemplares similares
-
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa
por: Jeon, In Kyung, et al.
Publicado: (2016) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
por: Ebens, Christen L
Publicado: (2021) -
A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis
por: McCann, Katelyn, et al.
Publicado: (2023)